GESSEL advised Maabarot Products on the sale of 100% shares in Laboratoria Natury to Farmaceutici Procemsa

27.01.2025 Case studies Mergers and acquisitions (M&A) Typical scope of services provided in an M&A transaction on the sell side Tax law Labour law, management contracts Private Equity

GESSEL advised Maabarot Products on the sale of 100% shares in Laboratoria Natury to Farmaceutici Procemsa

As a trusted legal advisor equipped to support clients throughout the entire investment lifecycle, we had the privilege of advising Maabarot Products Ltd., a company owned by Kibbutz Ma’abarot in Israel, on the sale of 100% shares in Laboratoria Natury sp. z o.o. to Farmaceutici Procemsa S.p.A. for a purchase price exceeding EUR 28 million. Laboratoria Natury specializes in the development and production of dietary supplements operating within a CDMO model.

The transaction also encompassed the repayment of financing provided to the target company by Maabarot Products Ltd. Our team was actively involved at every stage of the project, delivering comprehensive transactional support, including negotiations and the preparation of transaction documentation.

“The sale of Laboratoria Natury marks an end of one chapter for Maabarot, while simultaneously opening another, paving the way for further growth and new challenges. We have entrusted Laboratoria Natury into good hands, hoping for the company’s continued success with its new partner on board. We are delighted that once again, GESSEL law firm team comprehensively supported us during the negotiation process and closing of the transaction.” – says Yariv Grinberg, CEO of Maabarot Products Ltd.

“I just want to say thank you on behalf of all Maabarot team to Marcin, Ola and Diana from the GESSEL team. You made a tremendous work, and you were true partners throughout the whole process.” – says Rony Michaeli, VP of Business Development & Strategy of Maabarot Products Ltd.

“GESSEL’s relationship with Maabarot Products Ltd. dates to 2011, when we had the privilege of advising on the acquisition of shares in Laboratoria Natury sp. z o.o. This achievement reflects how, with the guidance of the right legal team, a smooth transition and maximum value for all stakeholders can be successfully realized. We are grateful for the trust placed in us and remain committed to leveraging our strategic vision and market expertise to deliver exceptional outcomes.” – says Marcin Macieszczak, Managing Partner, GESSEL.

 

Lawyers involved in the project

GESSEL advised Maabarot Products on the sale of 100% shares in Laboratoria Natury to Farmaceutici Procemsa

Marcin Macieszczak

Managing partner
Attorney-at-law

Mergers and acquisitions (M&A) | Private Equity

Marcin Macieszczak
GESSEL advised Maabarot Products on the sale of 100% shares in Laboratoria Natury to Farmaceutici Procemsa

Dominika Ramírez-Wołkiewicz

Partner
Attorney
Licensed tax advisor

Tax law | Private Clients

Dominika Ramírez-Wołkiewicz
GESSEL advised Maabarot Products on the sale of 100% shares in Laboratoria Natury to Farmaceutici Procemsa

Adam Kraszewski

Partner
Attorney-at-law

Labour law, management contracts | Intellectual property law | Life Sciences and Health Care

Adam Kraszewski
GESSEL advised Maabarot Products on the sale of 100% shares in Laboratoria Natury to Farmaceutici Procemsa

Aleksandra Szyszko-Kamińska

Managing Associate
Attorney-at-law

Mergers and acquisitions (M&A)

Aleksandra Szyszko-Kamińska
GESSEL advised Maabarot Products on the sale of 100% shares in Laboratoria Natury to Farmaceutici Procemsa

Diana Strzałkowska-Grad

Senior Associate
Attorney-at-law

Mergers and acquisitions (M&A)

Diana Strzałkowska-Grad
GESSEL advised Maabarot Products on the sale of 100% shares in Laboratoria Natury to Farmaceutici Procemsa

Anna Komorzycka

Associate

Mergers and acquisitions (M&A) | Corporate law

Anna Komorzycka

You may also like

23.03.2026

GESSEL advises on Vinci’s acquisition of control over MEWO

GESSEL advised MEWO S.A. and its shareholders on Vinci’s PLN 62.5 million investment in MEWO. Vinci is an investment fund within the group of Poland’s state development ...

Case studies
GESSEL advises on Vinci’s acquisition of control over MEWO

18.03.2026

GESSEL advises Cavatina Holding on PLN 250 million bond issuance programme

GESSEL advised Cavatina Holding S.A., a Warsaw Stock Exchange-listed commercial real estate developer, on the establishment of its fifth base prospectus bond issuance pr...

Case studies
GESSEL advises Cavatina Holding on PLN 250 million bond issuance programme
Wszystkie case studies

Do you want to be up to date?

Subscribe to the newsletter!

GESSEL advised Maabarot Products on the sale of 100% shares in Laboratoria Natury to Farmaceutici Procemsa